Drug-Drug Interactions : Mood Stabilizers and Anti-Anxiety Drugs

약물상호작용 : 기분안정제와 항불안제

  • Kim, Young Hoon (Department of Neuropsychiatry, School of Medicine, and Institute of Neuroscience, Inje University) ;
  • Rhee, Jung Goo (Department of Neuropsychiatry, School of Medicine, and Institute of Neuroscience, Inje University)
  • 김영훈 (인제대학교 의과대학 신경정신과학교실 및 신경과학연구소) ;
  • 이정구 (인제대학교 의과대학 신경정신과학교실 및 신경과학연구소)
  • Published : 2000.06.30

Abstract

Pharmacotherapy of bipolar disorder is a rapidly evolving field. Mood stabilizers and anticonvulsants have varying biochemical profiles which may predispose them to different adverse effects and drug-drug interactions. Several of the new anticonvulsants appear less likely to have the problems with drug-drug interaction. To provide more effective combination pharmacotherapies, clinicians should be allowed to anticipate and avoid pharmacokinetic and pharmacodynamic drug-drug interactions. We reviewed the role of cytochrome P450 isozymes in the metabolism of the drugs and their interactions. The drug-drug interactions of several classes of drugs which used as mood stabilizers and new anticonvulsants, some of which may have psychotropic profiles, are discussed mainly in this article. Finally, potential pharmacokinetic interactions between the benzodiazepines and other coadministered drugs are discussed briefly.

Keywords